Clinical trials
Recruiting Phase 2/3 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 1 |
| Eastern Hepatobiliary Surgery Hospital | 1 |
| Guangxi Medical University | 1 |
| Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | 1 |
| Inova Health Care Services | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Tuen Mun Hospital | 1 |
| UNICANCER | 1 |
| Zhujiang Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 10 |
| Breast Neoplasms | 1 |
| Colonic Neoplasms | 1 |
| Fibrosis | 1 |
| Head and Neck Neoplasms | 1 |
| Kidney Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Melanoma | 1 |
| Ovarian Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.